Pharmaceuticals companies are experiencing a period of unprecedented change. Driven by shifts in age and demographics, disease, the entry of new technologies, increased government regulations, and the pace of health care inflation, pharmaceuticals companies will have to dramatically change in order to cope with the future industry environment. The Life Sciences European practice along with Deloitte member firms worldwide can help you address these and other challenges in today's complex life sciences environment.